Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3

J Immunol. 2009 May 15;182(10):5899-903. doi: 10.4049/jimmunol.0804388.

Abstract

Histone deacetylase (HDAC) inhibition modulates dendritic cell (DC) functions and regulates experimental graft-vs-host disease and other immune-mediated diseases. The mechanisms by which HDAC inhibition modulates immune responses remain largely unknown. STAT-3 is a transcription factor shown to negatively regulate DC functions. In this study we report that HDAC inhibition acetylates and activates STAT-3, which regulates DCs by promoting the transcription of IDO. These findings demonstrate a novel functional role for posttranslational modification of STAT-3 through acetylation and provide mechanistic insights into HDAC inhibition-mediated immunoregulation by induction of IDO.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetylation
  • Animals
  • Blotting, Western
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Histone Deacetylase Inhibitors*
  • Histone Deacetylases / drug effects
  • Immunoprecipitation
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / immunology
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Oligonucleotide Array Sequence Analysis
  • Protein Processing, Post-Translational* / drug effects
  • Reverse Transcriptase Polymerase Chain Reaction
  • STAT3 Transcription Factor / immunology
  • STAT3 Transcription Factor / metabolism*

Substances

  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • STAT3 Transcription Factor
  • Histone Deacetylases